Astria Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Astria Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2024.
  • Astria Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$29M, a 43.4% decline year-over-year.
  • Astria Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$116M, a 84% decline year-over-year.
  • Astria Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$83M, a 55.2% decline from 2022.
  • Astria Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$53.5M, a 72.6% increase from 2021.
  • Astria Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$195M, a 421% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$116M -$29M -$8.78M -43.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$107M -$28.8M -$13.7M -90.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$93.7M -$24.2M -$10.7M -79% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$83M -$34.2M -$19.9M -139% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-04
Q3 2023 -$63.1M -$20.2M -$7.85M -63.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$55.3M -$15.1M -$3.65M -31.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$51.6M -$13.5M +$1.89M +12.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$53.5M -$14.3M -$4.78M -50.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-04
Q3 2022 -$48.7M -$12.4M -$4.49M -56.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$44.2M -$11.4M -$3.96M -52.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$40.3M -$15.4M +$155M +91% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$195M -$9.51M -$530K -5.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$194M -$7.9M +$2.97M +27.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$197M -$7.49M +$2.07M +21.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$199M -$170M -$162M -2015% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$37.4M -$8.98M -$2.23M -33.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$35.2M -$10.9M -$4.18M -62.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$31M -$9.55M -$2.23M -30.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$28.8M -$8.04M -$1.71M -27% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$27.1M -$6.75M -$659K -10.8% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-19
Q3 2019 -$26.4M -$6.68M -$674K -11.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$25.8M -$7.33M -$689K -10.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$25.1M -$6.33M +$1.31M +17.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$26.4M -$6.09M -$591K -10.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-10
Q3 2018 -$25.8M -$6.01M +$944K +13.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$26.7M -$6.64M +$283K +4.09% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$27M -$7.64M +$122K +1.57% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$27.1M -$5.5M +$3.28M +37.4% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-15
Q3 2017 -$30.4M -$6.95M +$1.47M +17.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$31.9M -$6.92M +$2.53M +26.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$34.4M -$7.76M +$1.66M +17.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$36.1M -$8.78M +$828K +8.62% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$36.9M -$8.42M +$66K +0.78% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$37M -$9.45M -$1.41M -17.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$35.5M -$9.42M -$2.92M -44.9% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 -$32.6M -$9.61M -$3.58M -59.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$29.1M -$8.49M -$2.46M -40.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$26.6M -$8.04M -$2.68M -49.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$23.9M -$6.5M -$2.03M -45.4% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$21.9M -$6.03M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$6.03M Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$5.36M Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$4.47M Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.